A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 TRIAL OF TADALAFIL FOR DUCHENNE MUSCULAR DYSTROPHY

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)

Bhavaraju-Sanka,Ratna K.

Funded by

LILLY RESEARCH LABORATORIES

Research Start Date

01/01/2017

Status

Inactive

Clinical Care

Drug Discovery

Neuroscience

Bioscience Research Panel